 | • レポートコード：QYR9ST01884 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の抗肥満処方薬市場について調査・分析し、以下の構成でお届け致します。抗肥満処方薬の種類別には、オルリスタット、フェンテルミン及びトピラマート、ブプロピオン及びナルトレキソン、ロカセリン、リラグルチドに、用途別には、小児、大人に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別抗肥満処方薬売上データ ・地域別抗肥満処方薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別抗肥満処方薬市場規模：オルリスタット、フェンテルミン及びトピラマート、ブプロピオン及びナルトレキソン、ロカセリン、リラグルチド ・用途別抗肥満処方薬市場規模：小児、大人 ・主要メーカーの企業情報：F Hoffmann La Roche Ltd、Orexigen Therapeutics、Novo Nordisk A/s、Arena Pharmaceuticals、Glaxosmithkline、Vivus、Boehringer Ingelheim、Alizyme ・抗肥満処方薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle such as intake of drugs due to stress, alcohol leads to growing demand for obesity management resulting in growth of this trend.The global Anti-Obesity Prescription Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 5.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-Obesity Prescription Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Anti-Obesity Prescription Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Obesity Prescription Drugs in these regions.
This research report categorizes the global Anti-Obesity Prescription Drugs market by top players/brands, region, type and end user. This report also studies the global Anti-Obesity Prescription Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
Market size by Product
Orlistat
Phentermine and Topiramate
Bupropion and Naltrexone
Lorcaserin
Liraglutide
Market size by End User
Pediatric
Adult
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Anti-Obesity Prescription Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Anti-Obesity Prescription Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-Obesity Prescription Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Anti-Obesity Prescription Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Anti-Obesity Prescription Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Obesity Prescription Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Anti-Obesity Prescription Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Product
1.4.2 Orlistat
1.4.3 Phentermine and Topiramate
1.4.4 Bupropion and Naltrexone
1.4.5 Lorcaserin
1.4.6 Liraglutide
1.5 Market by End User
1.5.1 Global Anti-Obesity Prescription Drugs Market Size Growth Rate by End User
1.5.2 Pediatric
1.5.3 Adult
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Obesity Prescription Drugs Market Size
2.1.1 Global Anti-Obesity Prescription Drugs Revenue 2014-2025
2.1.2 Global Anti-Obesity Prescription Drugs Sales 2014-2025
2.2 Anti-Obesity Prescription Drugs Growth Rate by Regions
2.2.1 Global Anti-Obesity Prescription Drugs Sales by Regions
2.2.2 Global Anti-Obesity Prescription Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-Obesity Prescription Drugs Sales by Manufacturers
3.1.1 Anti-Obesity Prescription Drugs Sales by Manufacturers
3.1.2 Anti-Obesity Prescription Drugs Sales Market Share by Manufacturers
3.1.3 Global Anti-Obesity Prescription Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Obesity Prescription Drugs Revenue by Manufacturers
3.2.1 Anti-Obesity Prescription Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Anti-Obesity Prescription Drugs Price by Manufacturers
3.4 Anti-Obesity Prescription Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Obesity Prescription Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Obesity Prescription Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Obesity Prescription Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anti-Obesity Prescription Drugs Sales by Product
4.2 Global Anti-Obesity Prescription Drugs Revenue by Product
4.3 Anti-Obesity Prescription Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anti-Obesity Prescription Drugs Breakdown Data by End User
6 North America
6.1 North America Anti-Obesity Prescription Drugs by Countries
6.1.1 North America Anti-Obesity Prescription Drugs Sales by Countries
6.1.2 North America Anti-Obesity Prescription Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-Obesity Prescription Drugs by Product
6.3 North America Anti-Obesity Prescription Drugs by End User
7 Europe
7.1 Europe Anti-Obesity Prescription Drugs by Countries
7.1.1 Europe Anti-Obesity Prescription Drugs Sales by Countries
7.1.2 Europe Anti-Obesity Prescription Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Obesity Prescription Drugs by Product
7.3 Europe Anti-Obesity Prescription Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Anti-Obesity Prescription Drugs by Countries
8.1.1 Asia Pacific Anti-Obesity Prescription Drugs Sales by Countries
8.1.2 Asia Pacific Anti-Obesity Prescription Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-Obesity Prescription Drugs by Product
8.3 Asia Pacific Anti-Obesity Prescription Drugs by End User
9 Central & South America
9.1 Central & South America Anti-Obesity Prescription Drugs by Countries
9.1.1 Central & South America Anti-Obesity Prescription Drugs Sales by Countries
9.1.2 Central & South America Anti-Obesity Prescription Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-Obesity Prescription Drugs by Product
9.3 Central & South America Anti-Obesity Prescription Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Anti-Obesity Prescription Drugs by Countries
10.1.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales by Countries
10.1.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-Obesity Prescription Drugs by Product
10.3 Middle East and Africa Anti-Obesity Prescription Drugs by End User
11 Company Profiles
11.1 F Hoffmann La Roche Ltd
11.1.1 F Hoffmann La Roche Ltd Company Details
11.1.2 Company Business Overview
11.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Products Offered
11.1.5 F Hoffmann La Roche Ltd Recent Development
11.2 Orexigen Therapeutics
11.2.1 Orexigen Therapeutics Company Details
11.2.2 Company Business Overview
11.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Products Offered
11.2.5 Orexigen Therapeutics Recent Development
11.3 Novo Nordisk A/s
11.3.1 Novo Nordisk A/s Company Details
11.3.2 Company Business Overview
11.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Products Offered
11.3.5 Novo Nordisk A/s Recent Development
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Products Offered
11.4.5 Arena Pharmaceuticals Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Details
11.5.2 Company Business Overview
11.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Products Offered
11.5.5 Glaxosmithkline Recent Development
11.6 Vivus
11.6.1 Vivus Company Details
11.6.2 Company Business Overview
11.6.3 Vivus Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Vivus Anti-Obesity Prescription Drugs Products Offered
11.6.5 Vivus Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Company Business Overview
11.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Products Offered
11.7.5 Boehringer Ingelheim Recent Development
11.8 Alizyme
11.8.1 Alizyme Company Details
11.8.2 Company Business Overview
11.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Alizyme Anti-Obesity Prescription Drugs Products Offered
11.8.5 Alizyme Recent Development
12 Future Forecast
12.1 Anti-Obesity Prescription Drugs Market Forecast by Regions
12.1.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Anti-Obesity Prescription Drugs Revenue Forecast by Regions 2019-2025
12.2 Anti-Obesity Prescription Drugs Market Forecast by Product
12.2.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Anti-Obesity Prescription Drugs Revenue Forecast by Product 2019-2025
12.3 Anti-Obesity Prescription Drugs Market Forecast by End User
12.4 North America Anti-Obesity Prescription Drugs Forecast
12.5 Europe Anti-Obesity Prescription Drugs Forecast
12.6 Asia Pacific Anti-Obesity Prescription Drugs Forecast
12.7 Central & South America Anti-Obesity Prescription Drugs Forecast
12.8 Middle East and Africa Anti-Obesity Prescription Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Obesity Prescription Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Anti-Obesity Prescription Drugs Product Picture
Table Anti-Obesity Prescription Drugs Market Segments
Table Key Manufacturers Anti-Obesity Prescription Drugs Covered
Table Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Product 2014-2025
Figure Orlistat Product Picture
Table Major Manufacturers of Orlistat
Figure Phentermine and Topiramate Product Picture
Table Major Manufacturers of Phentermine and Topiramate
Figure Bupropion and Naltrexone Product Picture
Table Major Manufacturers of Bupropion and Naltrexone
Figure Lorcaserin Product Picture
Table Major Manufacturers of Lorcaserin
Figure Liraglutide Product Picture
Table Major Manufacturers of Liraglutide
Table Global Anti-Obesity Prescription Drugs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Pediatric
Figure Adult
Figure Anti-Obesity Prescription Drugs Report Years Considered
Figure Global Anti-Obesity Prescription Drugs Market Size 2014-2025 (Million US$)
Figure Global Anti-Obesity Prescription Drugs Sales 2014-2025 (K MT)
Table Global Anti-Obesity Prescription Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Anti-Obesity Prescription Drugs Sales by Regions 2014-2019 (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Market Share by Regions 2014-2019
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Anti-Obesity Prescription Drugs Sales Market Share by Regions
Table Global Anti-Obesity Prescription Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions 2014-2019
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions
Table Global Anti-Obesity Prescription Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Anti-Obesity Prescription Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Anti-Obesity Prescription Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2014-2019)
Figure Anti-Obesity Prescription Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Anti-Obesity Prescription Drugs Price (2014-2019) (USD/MT)
Table Anti-Obesity Prescription Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-Obesity Prescription Drugs Product Type
Table Date of International Manufacturers Enter into Anti-Obesity Prescription Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-Obesity Prescription Drugs Sales by Product (2014-2019) (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Share by Product (2014-2019)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Product (2014-2019)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Product in 2018
Table Global Anti-Obesity Prescription Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Anti-Obesity Prescription Drugs Revenue Share by Product (2014-2019)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Product (2014-2019)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Product in 2018
Table Anti-Obesity Prescription Drugs Price by Product 2014-2019 (USD/MT)
Table Global Anti-Obesity Prescription Drugs Sales by End User (2014-2019) (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Share by End User (2014-2019)
Figure Global Sales Anti-Obesity Prescription Drugs Market Share by End User (2014-2019)
Figure Global Sales Anti-Obesity Prescription Drugs Market Share by End User in 2018
Figure North America Anti-Obesity Prescription Drugs Sales Growth Rate 2014-2019 (K MT)
Figure North America Anti-Obesity Prescription Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Anti-Obesity Prescription Drugs Sales by Countries (2014-2019) (K MT)
Table North America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Anti-Obesity Prescription Drugs Sales Market Share by Countries
Table North America Anti-Obesity Prescription Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries
Figure United States Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure United States Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Canada Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Anti-Obesity Prescription Drugs Sales by Product (2014-2019) (K MT)
Table North America Anti-Obesity Prescription Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Anti-Obesity Prescription Drugs Market Share by Product
Table North America Anti-Obesity Prescription Drugs Sales by End User (2014-2019) (K MT)
Table North America Anti-Obesity Prescription Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Anti-Obesity Prescription Drugs Market Share by End User
Figure Europe Anti-Obesity Prescription Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Europe Anti-Obesity Prescription Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Anti-Obesity Prescription Drugs Sales by Countries (2014-2019) (K MT)
Table Europe Anti-Obesity Prescription Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-Obesity Prescription Drugs Sales Market Share by Countries
Table Europe Anti-Obesity Prescription Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-Obesity Prescription Drugs Revenue Market Share by Countries
Figure Germany Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Germany Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure France Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure UK Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Italy Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Russia Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Anti-Obesity Prescription Drugs Sales by Product (2014-2019) (K MT)
Table Europe Anti-Obesity Prescription Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Anti-Obesity Prescription Drugs Market Share by Product
Table Europe Anti-Obesity Prescription Drugs Sales by End User (2014-2019) (K MT)
Table Europe Anti-Obesity Prescription Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Anti-Obesity Prescription Drugs Market Share by End User
Figure Asia Pacific Anti-Obesity Prescription Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Anti-Obesity Prescription Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Anti-Obesity Prescription Drugs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Anti-Obesity Prescription Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-Obesity Prescription Drugs Sales Market Share by Countries
Table Asia Pacific Anti-Obesity Prescription Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Countries
Figure China Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure China Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Australia Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Anti-Obesity Prescription Drugs Sales by Product (2014-2019) (K MT)
Table Asia Pacific Anti-Obesity Prescription Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Anti-Obesity Prescription Drugs Market Share by Product
Table Asia Pacific Anti-Obesity Prescription Drugs Sales by End User (2014-2019) (K MT)
Table Asia Pacific Anti-Obesity Prescription Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Anti-Obesity Prescription Drugs Market Share by End User
Figure Central & South America Anti-Obesity Prescription Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Anti-Obesity Prescription Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Anti-Obesity Prescription Drugs Sales by Countries (2014-2019) (K MT)
Table Central & South America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-Obesity Prescription Drugs Sales Market Share by Countries
Table Central & South America Anti-Obesity Prescription Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-Obesity Prescription Drugs Revenue Market Share by Countries
Figure Brazil Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Anti-Obesity Prescription Drugs Sales by Product (2014-2019) (K MT)
Table Central & South America Anti-Obesity Prescription Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Anti-Obesity Prescription Drugs Market Share by Product
Table Central & South America Anti-Obesity Prescription Drugs Sales by End User (2014-2019) (K MT)
Table Central & South America Anti-Obesity Prescription Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Anti-Obesity Prescription Drugs Market Share by End User
Figure Middle East and Africa Anti-Obesity Prescription Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Countries
Table Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries
Figure GCC Countries Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Anti-Obesity Prescription Drugs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Anti-Obesity Prescription Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Anti-Obesity Prescription Drugs Market Share by Product
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Anti-Obesity Prescription Drugs Market Share by End User
Table F Hoffmann La Roche Ltd Company Details
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table F Hoffmann La Roche Ltd Recent Development
Table Orexigen Therapeutics Company Details
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Orexigen Therapeutics Recent Development
Table Novo Nordisk A/s Company Details
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novo Nordisk A/s Recent Development
Table Arena Pharmaceuticals Company Details
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Arena Pharmaceuticals Recent Development
Table Glaxosmithkline Company Details
Table Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Glaxosmithkline Recent Development
Table Vivus Company Details
Table Vivus Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Vivus Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Alizyme Company Details
Table Alizyme Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Alizyme Recent Development
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Regions 2019-2025 (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Anti-Obesity Prescription Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Product 2019-2025 (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Anti-Obesity Prescription Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Anti-Obesity Prescription Drugs Sales Forecast by End User 2019-2025 (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Anti-Obesity Prescription Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Anti-Obesity Prescription Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Anti-Obesity Prescription Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Anti-Obesity Prescription Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Anti-Obesity Prescription Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Anti-Obesity Prescription Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Anti-Obesity Prescription Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Anti-Obesity Prescription Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Anti-Obesity Prescription Drugs Value Chain
Table Anti-Obesity Prescription Drugs Customers List
Table Anti-Obesity Prescription Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の処方整形外科薬市場：専門的調査 The prescription drugs are widely used for orthopedic surgery, which are used to treat arthritis, gout and others. The global Prescription Orthopedic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This re…- 世界の処方胃腸薬市場：専門的調査 The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders. The global …
- 抗自殺薬の世界市場：インサイト・予測 Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for p…
- 抗出血薬の世界市場：インサイト・予測 This reprot mainly studies Anti-bleeding Drugs market, Anti-bleeding Drugs are drugs that prevent or reduce coagulation of blood, prolonging the clotting time. Global Anti-bleeding Drug market is showing a positive trend of growth around the globe. There are many factors which are indicating a posit…
- 処方皮膚科治療の世界市場：市場規模・現状・予測 Based on product types,the psoriasis drugs segment dominated the global market prescription dermatology therapeutics in 2017.In 2018, the global Prescription Dermatology Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% duri…